Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (OTC Pink - Current Information:AZNCF)

Delayed Data
As of Jun 30
 +1.34 / +2.30%
Today’s Change
Today|||52-Week Range
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
Jun 30 / MotleyFool.com - Paid Partner Content
Post-Brexit Analysis: Should Investors Buy or Sell Biopharma?
Jun 24 / MotleyFool.com - Paid Partner Content
ACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's Why
Jun 28 / MotleyFool.com - Paid Partner Content
AstraZeneca Nasal Spray Flu Vaccine To be Hit By ACIP Vote
Jun 23 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Moving On Heavy Pre-Market Trading
Jun 28 / TheStreet.com - Paid Partner Content
7 Pharmaceutical Stocks With Dividends Yielding More Than 3%
Jun 21 / MotleyFool.com - Paid Partner Content
Frontrunning: June 28
Jun 28 / Investing Channel - Paid Partner Content
This New Class Of Medicine Could Reshape Diabetes Treatment
Jun 20 / MotleyFool.com - Paid Partner Content
The Brexit Vote Is Crushing These 3 Clinical-Stage Biotech Stocks
Jun 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close58.35
Today’s open59.50
Day’s range59.06 - 59.69
Average volume (3 months)1,344
Market cap$73.8B
Dividend yield5.02%
Data as of 2:53pm ET, 06/30/2016

Growth & Valuation

Earnings growth (last year)+127.55%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-5.32%
P/E ratio--


No competitors data available.


Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$24.7B
Annual profit (last year)$2.8B
Net profit margin11.43%


Health Technology
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Pascal Soriot
Executive VP-Operations &
Information Technology
Pam P. Cheng
Corporate headquarters
London, Greater London


Partner Offers

Search for Jobs